Company Centogene N.V.

Equities

CNTG

NL0014040206

Biotechnology & Medical Research

Market Closed - Nasdaq 04:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
0.461 USD -3.96% Intraday chart for Centogene N.V. -3.98% -61.58%

Business Summary

Centogene N.V., is a commercial company. The company focuses on rare diseases, transforming clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. The company's platform includes epidemiological, phenotypic, and genetic data reflecting a global population, as well as a biobank of blood samples from these patients. The company's pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. The Company's Clinical Diagnostics segment provides targeted genetic sequencing and diagnostic services to patients through its distribution partners and customers, which are typically physicians, laboratories or hospitals.

Number of employees: 444

Sales per Business

USD in Million2021Weight2022Weight Delta
Diagnostics
66.1 %
33 14.7 % 33 66.1 % -0.06%
Pharmaceutical
33.9 %
18 8.2 % 17 33.9 % -8.39%

Sales per region

USD in Million2021Weight2022Weight Delta
United States
34.8 %
23 10.2 % 17 34.8 % -24.00%
Saudi Arabia
26.2 %
-- 13 26.2 % -
Middle East
15.8 %
19 8.7 % 8 15.8 % -59.48%
Europe
12.6 %
7 3.1 % 6 12.6 % -8.87%
Latin America
8.2 %
3 1.4 % 4 8.2 % +33.97%
Asia Pacific
1.7 %
1 0.4 % 1 1.7 % -14.56%
Germany
0.6 %
167 74.3 % 0 0.6 % -99.81%
North America
0.1 %
0 0.1 % 0 0.1 % -69.09%
Netherlands
0.0 %
4 1.9 % 0 0.0 % -99.83%

Managers

Managers TitleAgeSince
Chief Executive Officer 62 21-12-19
Director of Finance/CFO - 22-02-07
Chief Tech/Sci/R&D Officer 64 21-08-15
Chief Tech/Sci/R&D Officer 54 15-12-31
Investor Relations Contact - -
Corporate Officer/Principal - 15-04-30
Corporate Officer/Principal - 11-12-31
Sales & Marketing - -
Corporate Officer/Principal - -
Corporate Officer/Principal - 23-03-14

Members of the board

Members of the board TitleAgeSince
Chairman 57 20-03-15
Director/Board Member 57 17-06-30
Director/Board Member 66 19-03-31
Director/Board Member 68 16-12-31
Director/Board Member 46 18-12-31
Director/Board Member 52 20-11-09
Director/Board Member - 22-11-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 27,865,752 19,364,195 ( 69.49 %) 0 69.49 %

Shareholders

NameEquities%Valuation
DPE Deutsche Private Equity GmbH
27.77 %
7,739,658 27.77 % 5 M $
CareVentures SA
15.29 %
4,261,460 15.29 % 3 M $
TVM Capital GmbH
11.22 %
3,125,635 11.22 % 2 M $
Platinum Investment Management Ltd.
8.528 %
2,376,442 8.528 % 2 M $
ACATIS Investment Kapitalverwaltungsgesellschaft mbH
1.274 %
354,962 1.274 % 252 023 $
350,145 1.257 % 248 603 $
300,000 1.077 % 213 000 $
Wells Fargo Clearing Services LLC
0.7371 %
205,389 0.7371 % 145 826 $
Peer Schatz
0.3592 %
100,100 0.3592 % 71 071 $
Stifel, Nicolaus & Co., Inc.
0.0770 %
21,450 0.0770 % 15 230 $

Company contact information

Centogene NV

Am Strande 7

18055, Rostock

+49 381 80113 500

http://www.centogene.com
address Centogene N.V.(CNTG)
  1. Stock Market
  2. Equities
  3. CNTG Stock
  4. Company Centogene N.V.